Until now, an affordable repellent lotion had never been developed for those who suffer most from vector-borne disease: the poor.  Consequently, without such products in the stores, there are no sales data to support the conclusion that a market for them could exist.  However, because the misery level caused by nuisance mosquitoes and disease vectors is so high, and because positive results from extended product-acceptance trials with NO MO have been so impressive (> 97%), we've realized there is a pent up demand for products like NO MO in disease-endemic regions.  Therefore, we believe the commercial opportunity for manufacturers and distributors of such effective, low-cost products is great, and the "greater good" of disease reduction could be achieved by pioneering the development of this market.